[
  {
    "ts": null,
    "headline": "Hartford Equity Income Fund Q4 2024 Commentary",
    "summary": "Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=f95c07e653005714d4816a7784c66ad729b2d2ab7264888ba8a672949ffd2bed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740435780,
      "headline": "Hartford Equity Income Fund Q4 2024 Commentary",
      "id": 132867316,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2095584352/image_2095584352.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=f95c07e653005714d4816a7784c66ad729b2d2ab7264888ba8a672949ffd2bed"
    }
  },
  {
    "ts": null,
    "headline": "ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales",
    "summary": "Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven by strong Caplyta sales.",
    "url": "https://finnhub.io/api/news?id=105ac35349eeae7507561c5ed0117a0fbf23b5a9dbe60d9611ce01a75e0c68e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740414240,
      "headline": "ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales",
      "id": 132902106,
      "image": "https://media.zenfs.com/en/zacks.com/10bd0fa0a1c2e4ce5cbc86180cb9c3e4",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven by strong Caplyta sales.",
      "url": "https://finnhub.io/api/news?id=105ac35349eeae7507561c5ed0117a0fbf23b5a9dbe60d9611ce01a75e0c68e8"
    }
  },
  {
    "ts": null,
    "headline": "5 Stocks in the Dow ETF That Survived the Worst Week Since October",
    "summary": "Dow Jones witnesses its biggest weekly drop since October amid renewed concerns about economic growth. Let's look at the stocks that survived.",
    "url": "https://finnhub.io/api/news?id=e894b5e16793a4cfd387ad5e40e5a477b01ade53509a6648ea5d7324605dc266",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740407400,
      "headline": "5 Stocks in the Dow ETF That Survived the Worst Week Since October",
      "id": 132902108,
      "image": "https://media.zenfs.com/en/zacks.com/9c38b3b02b2094b085cc6b74cad18c01",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Dow Jones witnesses its biggest weekly drop since October amid renewed concerns about economic growth. Let's look at the stocks that survived.",
      "url": "https://finnhub.io/api/news?id=e894b5e16793a4cfd387ad5e40e5a477b01ade53509a6648ea5d7324605dc266"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) the Best DRIP Stock to Own Now?",
    "summary": "We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best DRIP stocks to own now. Dividend investing is often regarded as a strategy that rewards patience, as it tends to generate stronger […]",
    "url": "https://finnhub.io/api/news?id=a32e1faff070a148bbdd8997ff388b4475be5c3133a1a4be8157dcadff975c72",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740407266,
      "headline": "Is Johnson & Johnson (JNJ) the Best DRIP Stock to Own Now?",
      "id": 132902109,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best DRIP stocks to own now. Dividend investing is often regarded as a strategy that rewards patience, as it tends to generate stronger […]",
      "url": "https://finnhub.io/api/news?id=a32e1faff070a148bbdd8997ff388b4475be5c3133a1a4be8157dcadff975c72"
    }
  },
  {
    "ts": null,
    "headline": "LVHD: Seeking Low Volatility In High Dividends With Average Result",
    "summary": "Franklin LVHD ETF: Explore a 111-stock portfolio with value traits focusing on utilities and staples.",
    "url": "https://finnhub.io/api/news?id=f3ae1815bf8e049a8bf4da12cca0f8d9140e318c9ff15a15b8e43c15cf43fc08",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740404809,
      "headline": "LVHD: Seeking Low Volatility In High Dividends With Average Result",
      "id": 132865142,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478479389/image_1478479389.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Franklin LVHD ETF: Explore a 111-stock portfolio with value traits focusing on utilities and staples.",
      "url": "https://finnhub.io/api/news?id=f3ae1815bf8e049a8bf4da12cca0f8d9140e318c9ff15a15b8e43c15cf43fc08"
    }
  },
  {
    "ts": null,
    "headline": "2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream",
    "summary": "A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.  Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are two very healthy, high-yielding dividend stocks.  Medtronic currently has a 3.1% dividend yield.",
    "url": "https://finnhub.io/api/news?id=804a4e03e1761ff8d5d5ed99bfeadefbc6e8ac22668b18d93569a11ba58df2fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740400200,
      "headline": "2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream",
      "id": 132902111,
      "image": "https://g.foolcdn.com/editorial/images/808618/stethoscope-on-money-cash-1200x801-d21b45d.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.  Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are two very healthy, high-yielding dividend stocks.  Medtronic currently has a 3.1% dividend yield.",
      "url": "https://finnhub.io/api/news?id=804a4e03e1761ff8d5d5ed99bfeadefbc6e8ac22668b18d93569a11ba58df2fc"
    }
  },
  {
    "ts": null,
    "headline": "TREMFYA (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis",
    "summary": "SPRING HOUSE, Pa. - Johnson & Johnson today announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous induction therapy in adults with moderately to severely active ulcerative colitis at...",
    "url": "https://finnhub.io/api/news?id=ca1e490bd4ba2cb86816f09834a1398e078a0f0d25f51aa0612045d7d8311788",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740395299,
      "headline": "TREMFYA (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis",
      "id": 132864245,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "SPRING HOUSE, Pa. - Johnson & Johnson today announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous induction therapy in adults with moderately to severely active ulcerative colitis at...",
      "url": "https://finnhub.io/api/news?id=ca1e490bd4ba2cb86816f09834a1398e078a0f0d25f51aa0612045d7d8311788"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson MedTech Celebrates Inaugural National Heart Recovery Awareness Day",
    "summary": "DANVERS, Mass- Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery Awareness Day today, February 20. Recognized through a U.S....",
    "url": "https://finnhub.io/api/news?id=67fb5915f6756cf9ec01e14bc1fd181ef3337fbdc8978b8a5b0505fd8d0fc766",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740392599,
      "headline": "Johnson & Johnson MedTech Celebrates Inaugural National Heart Recovery Awareness Day",
      "id": 132863952,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "DANVERS, Mass- Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery Awareness Day today, February 20. Recognized through a U.S....",
      "url": "https://finnhub.io/api/news?id=67fb5915f6756cf9ec01e14bc1fd181ef3337fbdc8978b8a5b0505fd8d0fc766"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Balanced Income Fund Q4 2024 Commentary",
    "summary": "Hartford Balanced Income Fund (I Share) underperformed its benchmark. Global fixed-income markets generated negative total returns during the fourth quarter.",
    "url": "https://finnhub.io/api/news?id=8cf846021938805f1fdc3762989c1b2cfb2067476155afc8ecef7b18a85d910e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740378240,
      "headline": "Hartford Balanced Income Fund Q4 2024 Commentary",
      "id": 132862608,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170553469/image_2170553469.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Hartford Balanced Income Fund (I Share) underperformed its benchmark. Global fixed-income markets generated negative total returns during the fourth quarter.",
      "url": "https://finnhub.io/api/news?id=8cf846021938805f1fdc3762989c1b2cfb2067476155afc8ecef7b18a85d910e"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Dividend Income Fund Q4 2024 Commentary",
    "summary": "Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=4fb2ba289dc911d2ffc3f50d8dc7e2158e47042abde7d0b7b284ce352cacdecf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740375300,
      "headline": "Columbia Dividend Income Fund Q4 2024 Commentary",
      "id": 132862367,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1456260650/image_1456260650.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=4fb2ba289dc911d2ffc3f50d8dc7e2158e47042abde7d0b7b284ce352cacdecf"
    }
  }
]